首页> 美国卫生研究院文献>Bulletin of the World Health Organization >Studies on the pharmacokinetics of primaquine
【2h】

Studies on the pharmacokinetics of primaquine

机译:伯氨喹的药代动力学研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A sensitive and specific assay for primaquine in plasma and urine using gas chromatography/mass spectrometry has been developed and used to study the plasma kinetics of primaquine. Preliminary studies on the effects of single and multiple oral doses have been carried out. In both cases the drug was completely, or almost completely, removed from the plasma in 24 h. The concentration of primaquine in the plasma usually reached a peak 1-2 hours after oral administration. The plasma elimination half-life was about 4 h. Less than 1% of the dose was detected in the urine collected over a 24-h period following drug ingestion. When Caucasian volunteers were given primaquine and chloroquine concurrently, some of them developed significant methaemoglobinaemia. Primaquine was not detectable in the plasma of any of the volunteers, 24 h after each daily dose.
机译:已经开发出了使用气相色谱/质谱法对血浆和尿液中的伯氨喹进行灵敏而特异的测定,并用于研究伯氨喹的血浆动力学。已经对单次和多次口服剂量的影响进行了初步研究。在这两种情况下,药物都在24小时内从血浆中完全或几乎完全去除。口服后1-2小时血浆中伯氨喹的浓度通常达到峰值。血浆消除半衰期约为4小时。摄入药物后24小时内在收集的尿液中检测不到不到1%的剂量。当高加索志愿者同时接受伯氨喹和氯喹治疗时,其中一些会发展成明显的血红蛋白血症。每天服药24小时后,任何志愿者的血浆中均未检出Primaquine。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号